•Nigeria’s defiance of WHO warning alarms experts
•Others disagree
By Chioma Obinna
Nigerian health professionals have raised concerns over the use of hydroxychloroquine and chloroquine for the treatment of COVID-19 patients in the country following the decision of the World Health Organisation, WHO, to halt the trial of the drugs for coronavirus treatment.
Although the professionals, who include toxicologists, pharmacists, dieticians and molecular laboratory scientists, are divided over the National Agency for Food and Drug Administration and Control, NAFDAC, decision to go ahead with the trial, some of them fear that many of the patients may die of heart disease, especially from the use of hydroxychloroquine.
WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, had, on Monday, announced the halting of the hydroxychloroquine trial following an observational study published in a medical journal, The Lancet, described how seriously ill COVID-19 patients who…
Source: Vanguard Newspaper
